03.11.2025 21:38
American personal care product manufacturer Kimberly-Clark has announced that it will acquire Kenvue, the maker of Tylenol, in a deal worth $48.7 billion. As a result of the agreement, Kenvue shareholders will receive payments, and the portfolios of the two companies will be combined through the merger.
```html
It has been reported that the American personal care product manufacturer Kimberly-Clark will acquire Kenvue, the producer of Tylenol, in a deal worth $48.7 billion.
In a statement from the companies, it was announced that Kimberly-Clark has reached an agreement to purchase all publicly traded shares of Kenvue in exchange for cash and stock.
THE SALE PRICE IS ASTOUNDING
The statement indicated that the acquisition values Kenvue at $48.7 billion, and Kenvue shareholders will receive $3.50 in cash and 0.14625 shares of Kimberly-Clark for each share.
The statement noted that a total cash payment of $6.8 billion will be made to Kenvue shareholders, and the total value per share is calculated to be $21.01.
EXPECTED TO BE COMPLETED IN 2026
The statement expressed that the acquisition is expected to be completed in the second half of 2026, and when the transaction is finalized, Kimberly-Clark shareholders will own 54% of the combined company, while Kenvue shareholders will own 46%.
In the statement, Kimberly-Clark CEO Mike Hsu emphasized their excitement about bringing the two companies together.
Hsu pointed out that the company has undergone a transformation in recent years to shift its portfolio towards areas of higher growth and profitability, stating that this acquisition is a "strong next step" in that journey.
Kenvue CEO Kirk Perry also stated, "Our merger with Kimberly-Clark brings together two portfolios filled with iconic, beloved brands and everyday needs that people trust and rely on throughout their lives, perfectly complementing each other."
WHAT HAPPENED?
Following U.S. President Donald Trump's association of acetaminophen, the active ingredient in Tylenol, with autism in September, Kenvue's shares had come under pressure.
```